Casdin Capital 13F holdings, Q1 2022
Holdings as of March 31, 2022 · filings on SEC EDGAR · latest filing →
Casdin Capital disclosed 47 US equity positions worth $2.2bn in its Q1 2022 13F filing. The largest position was BLFS at 7.7% of the reported book, followed by ALNY and EQRX INC. Against the Q4 2021 filing, it opened 2 new positions, added to 1 and reduced 7 among the top 47 holdings.
What did Casdin Capital own in Q1 2022? Top 47 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2021 |
|---|---|---|---|---|---|---|---|
| 1 | BLFS BIOLIFE SOLUTIONS INC | Healthcare | 7.7% | $172.0m | 7,566,292 | 0% | held |
| 2 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 7.3% | $163.3m | 1,000,000 | 0% | held |
| 3 | EQRX INC | 7.3% | $163.2m | 39,527,669 | 0% | held | |
| 4 | FATE FATE THERAPEUTICS INC | Healthcare | 5.9% | $131.8m | 3,400,000 | 0% | held |
| 5 | RLAY RELAY THERAPEUTICS INC | Healthcare | 5.2% | $115.4m | 3,857,253 | 0% | held |
| 6 | SOMALOGIC INC | 4.5% | $99.4m | 12,389,082 | 0% | held | |
| 7 | 2655787D BLUEPRINT MEDICINES CORP | 4.4% | $99.0m | 1,550,000 | 0% | held | |
| 8 | MXCT MAXCYTE INC | 4.4% | $97.7m | 13,971,334 | 0% | held | |
| 9 | INVITAE CORP | 4.4% | $97.3m | 12,203,669 | 0% | held | |
| 10 | EXK EXACT SCIENCES CORP | Basic Materials | 4.2% | $93.0m | 1,330,000 | -35% | reduced |
| 11 | PACB PACIFIC BIOSCIENCES CALIF IN | Healthcare | 3.3% | $72.7m | 7,990,652 | 0% | held |
| 12 | VERVE THERAPEUTICS INC | 3.2% | $71.6m | 3,138,167 | 0% | held | |
| 13 | ABSI ABSCI CORPORATION | 2.9% | $65.1m | 7,718,593 | 0% | held | |
| 14 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 2.8% | $62.5m | 800,000 | -41% | reduced |
| 15 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.7% | $60.8m | 2,090,000 | 0% | held |
| 16 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.7% | $60.5m | 2,370,000 | 0% | held |
| 17 | DNLI DENALI THERAPEUTICS INC | Healthcare | 2.2% | $48.3m | 1,500,000 | 0% | held |
| 18 | BEAM BEAM THERAPEUTICS INC | Healthcare | 2.1% | $46.9m | 818,820 | 0% | held |
| 19 | GLOBAL BLOOD THERAPEUTICS IN | 2.1% | $45.9m | 1,325,000 | 0% | held | |
| 20 | TWST TWIST BIOSCIENCE CORP | Healthcare | 1.9% | $43.5m | 880,000 | 31% | added |
| 21 | CDNA CAREDX INC | Healthcare | 1.9% | $42.7m | 1,153,335 | 0% | held |
| 22 | TNYA TENAYA THERAPEUTICS INC | 1.9% | $42.3m | 3,586,818 | 0% | held | |
| 23 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.9% | $41.6m | 5,487,910 | 0% | held |
| 24 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 1.8% | $40.4m | 3,206,380 | 0% | held |
| 25 | ONC BEIGENE LTD | Healthcare | 1.3% | $28.3m | 150,000 | 0% | held |
| 26 | GH GUARDANT HEALTH INC | Healthcare | 1.2% | $27.8m | 420,000 | -47% | reduced |
| 27 | DERMTECH INC | 1.1% | $25.6m | 1,745,000 | 0% | held | |
| 28 | GINKGO BIOWORKS HOLDINGS INC | 0.8% | $16.9m | 4,202,808 | -3% | reduced | |
| 29 | WGS SEMA4 HOLDINGS CORP | 0.7% | $15.3m | 5,000,000 | 0% | held | |
| 30 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 0.6% | $13.9m | 1,000,000 | 0% | held |
| 31 | GLUE MONTE ROSA THERAPEUTICS INC | 0.6% | $13.5m | 960,882 | 0% | held | |
| 32 | SEER SEER INC | 0.5% | $12.2m | 800,000 | 0% | held | |
| 33 | 2SEVENTY BIO INC | 0.5% | $10.5m | 614,754 | – | new | |
| 34 | EXSCIENTIA PLC | 0.5% | $10.3m | 713,900 | 0% | held | |
| 35 | GENERATION BIO CO | 0.4% | $9.7m | 1,324,275 | 0% | held | |
| 36 | SCIENCE 37 HOLDINGS INC | 0.4% | $9.6m | 1,800,000 | 0% | held | |
| 37 | SINGULAR GENOMICS SYSTEMS IN | 0.4% | $9.1m | 1,442,870 | 0% | held | |
| 38 | MIRATI THERAPEUTICS INC | 0.4% | $8.4m | 102,500 | – | new | |
| 39 | 4D MOLECULAR THERAPEUTICS IN | 0.4% | $8.4m | 555,455 | 0% | held | |
| 40 | MAGENTA THERAPEUTICS INC | 0.4% | $8.0m | 2,773,468 | -29% | reduced | |
| 41 | ZLAB ZAI LAB LTD | Healthcare | 0.3% | $6.6m | 150,000 | 0% | held |
| 42 | CDXS CODEXIS INC | Healthcare | 0.3% | $6.2m | 300,000 | -93% | reduced |
| 43 | KRONOS BIO INC | 0.2% | $4.2m | 583,436 | 0% | held | |
| 44 | RXRX RECURSION PHARMACEUTICALS IN | Healthcare | 0.2% | $3.9m | 548,156 | 0% | held |
| 45 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.1% | $3.2m | 601,515 | 0% | held |
| 46 | DECIBEL THERAPEUTICS INC | 0.0% | $1.0m | 330,000 | -72% | reduced | |
| 47 | LIANY LIANBIO | 0.0% | $766.0k | 206,415 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.